Pulmonx Corp. (LUNG)
2.06
-0.02
(-0.96%)
USD |
NASDAQ |
Sep 09, 12:07
Pulmonx Debt to Equity Ratio : 1.434 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.434 |
| March 31, 2026 | 1.230 |
| December 31, 2025 | 1.042 |
| September 30, 2025 | 0.9422 |
| June 30, 2025 | 0.8225 |
| March 31, 2025 | 0.7332 |
| December 31, 2024 | 0.6581 |
| September 30, 2024 | 0.5942 |
| June 30, 2024 | 0.5553 |
| March 31, 2024 | 0.3672 |
| December 31, 2023 | 0.3501 |
| September 30, 2023 | 0.3357 |
| June 30, 2023 | 0.321 |
| March 31, 2023 | 0.3028 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.1584 |
| September 30, 2022 | 0.154 |
| June 30, 2022 | 0.1502 |
| March 31, 2022 | 0.1456 |
| December 31, 2021 | 0.1369 |
| September 30, 2021 | 0.132 |
| June 30, 2021 | 0.1248 |
| March 31, 2021 | 0.1238 |
| December 31, 2020 | 0.1204 |
| September 30, 2020 | 80.61 |
| June 30, 2020 | -1.271 |
| March 31, 2020 | |
| December 31, 2019 | -1.212 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Abbott Laboratories | 0.638 |
| AngioDynamics, Inc. | 0.0641 |
| Alphatec Holdings, Inc. | 52.37 |
| AtriCure, Inc. | 0.1437 |
| Baxter International, Inc. | 1.427 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 114.73M |
| Total Liabilities (Quarterly) | 75.54M |
| Shareholders Equity (Quarterly) | 39.20M |
| Current Ratio | 4.319 |
| Net Debt Paydown Yield | 0.26% |